Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

22 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Longitudinal cohort study on the effectiveness of lipid apheresis treatment to reduce high lipoprotein(a) levels and prevent major adverse coronary events.
Jaeger BR, Richter Y, Nagel D, Heigl F, Vogt A, Roeseler E, Parhofer K, Ramlow W, Koch M, Utermann G, Labarrere CA, Seidel D; Group of Clinical Investigators. Jaeger BR, et al. Among authors: roeseler e. Nat Clin Pract Cardiovasc Med. 2009 Mar;6(3):229-39. doi: 10.1038/ncpcardio1456. Nat Clin Pract Cardiovasc Med. 2009. PMID: 19234501 Clinical Trial.
Current view: indications for extracorporeal lipid apheresis treatment.
Schettler V, Neumann CL, Hulpke-Wette M, Hagenah GC, Schulz EG, Wieland E; German Apheresis Working Group. Schettler V, et al. Clin Res Cardiol Suppl. 2012 Jun;7(Suppl 1):15-9. doi: 10.1007/s11789-012-0046-6. Clin Res Cardiol Suppl. 2012. PMID: 22528134 Free PMC article.
Lipoprotein apheresis in patients with maximally tolerated lipid-lowering therapy, lipoprotein(a)-hyperlipoproteinemia, and progressive cardiovascular disease: prospective observational multicenter study.
Leebmann J, Roeseler E, Julius U, Heigl F, Spitthoever R, Heutling D, Breitenberger P, Maerz W, Lehmacher W, Heibges A, Klingel R; Pro(a)LiFe Study Group*. Leebmann J, et al. Among authors: roeseler e. Circulation. 2013 Dec 17;128(24):2567-76. doi: 10.1161/CIRCULATIONAHA.113.002432. Epub 2013 Sep 20. Circulation. 2013. PMID: 24056686
First data from the German Lipoprotein Apheresis Registry (GLAR).
Schettler VJ, Neumann CL, Peter C, Zimmermann T, Julius U, Roeseler E, Heigl F, Ramlow W, Blume H; Scientific Board of GLAR for the German Apheresis Working Group. Schettler VJ, et al. Among authors: roeseler e. Atheroscler Suppl. 2015 May;18:41-4. doi: 10.1016/j.atherosclerosissup.2015.02.006. Atheroscler Suppl. 2015. PMID: 25936303
[Therapeutic algorithm for lipoprotein apheresis and PCSK9 inhibition for severe hypercholesterolemia or isolated lipoprotein(a) hyperlipoproteinemia].
Schettler VJ, Ringel J, Jacob S, Julius U, Klingel R, Heigl F, Roeseler E, Grützmacher P; Deutsche Gesellschaft für Nephrologie (DGfN); Verband Deutsche Nierenzentren (DN). Schettler VJ, et al. Among authors: roeseler e. Internist (Berl). 2016 May;57(5):511-6. doi: 10.1007/s00108-016-0043-9. Internist (Berl). 2016. PMID: 27118008 German. No abstract available.
Lipoprotein Apheresis for Lipoprotein(a)-Associated Cardiovascular Disease: Prospective 5 Years of Follow-Up and Apolipoprotein(a) Characterization.
Roeseler E, Julius U, Heigl F, Spitthoever R, Heutling D, Breitenberger P, Leebmann J, Lehmacher W, Kamstrup PR, Nordestgaard BG, Maerz W, Noureen A, Schmidt K, Kronenberg F, Heibges A, Klingel R; Pro(a)LiFe-Study Group. Roeseler E, et al. Arterioscler Thromb Vasc Biol. 2016 Sep;36(9):2019-27. doi: 10.1161/ATVBAHA.116.307983. Epub 2016 Jul 14. Arterioscler Thromb Vasc Biol. 2016. PMID: 27417585
The German Lipoprotein Apheresis Registry (GLAR) - almost 5 years on.
Schettler VJJ, Neumann CL, Peter C, Zimmermann T, Julius U, Roeseler E, Heigl F, Grützmacher P, Blume H, Vogt A; Scientific Board of GLAR for the German Apheresis Working Group. Schettler VJJ, et al. Among authors: roeseler e. Clin Res Cardiol Suppl. 2017 Mar;12(Suppl 1):44-49. doi: 10.1007/s11789-017-0089-9. Clin Res Cardiol Suppl. 2017. PMID: 28233268 Free PMC article.
Erratum to: The German Lipoprotein Apheresis Registry (GLAR) - almost 5 years on.
Schettler VJJ, Neumann CL, Peter C, Zimmermann T, Julius U, Roeseler E, Heigl F, Grützmacher P, Blume H, Vogt A; Scientific Board of GLAR for the German Apheresis Working Group. Schettler VJJ, et al. Among authors: roeseler e. Clin Res Cardiol Suppl. 2017 Jul 17. doi: 10.1007/s11789-017-0092-1. Online ahead of print. Clin Res Cardiol Suppl. 2017. PMID: 28717887 No abstract available.
Current insights into the German lipoprotein apheresis standard: PCSK9-inhibitors, lipoprotein apheresis or both?
Schettler VJJ, Ringel J, Jacob S, Julius U, Klingel R, Heigl F, Roeseler E, Grützmacher P; German Society of Nephrology (DGfN) and the Foundation of German Centers of Nephrology (DN). Schettler VJJ, et al. Among authors: roeseler e. Atheroscler Suppl. 2017 Nov;30:44-49. doi: 10.1016/j.atherosclerosissup.2017.05.005. Epub 2017 Jun 1. Atheroscler Suppl. 2017. PMID: 29096860 Review.
22 results